Here's Why Repligen Stock Gained 12.8% in March
Shares of Repligen (NASDAQ: RGEN) rose nearly 13% last month, according to data provided by S&P Global Market Intelligence. That easily bested the 12.5% drop of the S&P 500 in March. But the stock's performance probably had little to do with the coronavirus pandemic.
Investors likely remember that shares tumbled at the end of February when the company reported full-year 2019 operating results. The business delivered impressive revenue and earnings growth last year, but Repligen issued full-year 2020 guidance that disappointed Wall Street analysts.
In other words, Mr. Market figured shares of Repligen had already been through enough and didn't require a correction alongside the rest of the stock market. Investors might want to consider that the worst is yet to come for the growth stock.
Source Fool.com
